Natixis Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56.6M | Sell |
1,325,522
-542,522
| -29% | -$29.5M | 0.06% | 277 |
|
|
2026
Q1 | $117M | Sell |
1,868,044
-340,596
| -15% | -$27.2M | 0.16% | 136 |
|
|
2025
Q4 | $211M | Sell |
2,208,640
-298,125
| -12% | -$29.2M | 0.3% | 70 |
|
|
2025
Q3 | $245M | Buy |
2,506,765
+1,904
| +0.1% | +$197K | 0.36% | 45 |
|
|
2025
Q2 | $269M | Buy |
2,504,861
+338,446
| +16% | +$34.2M | 0.43% | 38 |
|
|
2025
Q1 | $219M | Buy |
2,166,415
+136,346
| +7% | +$13.7M | 0.4% | 44 |
|
|
2024
Q4 | $181M | Buy |
2,030,069
+184,264
| +10% | +$16.2M | 0.34% | 52 |
|
|
2024
Q3 | $155M | Buy |
1,845,805
+96,451
| +6% | +$7.6M | 0.3% | 64 |
|
|
2024
Q2 | $135M | Buy |
1,749,354
+64,068
| +4% | +$4.69M | 0.29% | 71 |
|
|
2024
Q1 | $115M | Sell |
1,685,286
-32,901
| -2% | -$2.12M | 0.27% | 90 |
|
|
2023
Q4 | $99.3M | Sell |
1,718,187
-57,240
| -3% | -$3.06M | 0.26% | 92 |
|
|
2023
Q3 | $93.7M | Buy |
1,775,427
+902,424
| +103% | +$47.3M | 0.29% | 81 |
|
|
2023
Q2 | $47.2M | Sell |
873,003
-159,008
| -15% | -$8.3M | 0.15% | 157 |
|
|
2023
Q1 | $51.6M | Sell |
1,032,011
-1,771
| -0.2% | -$83.5K | 0.18% | 137 |
|
|
2022
Q4 | $47.8M | Buy |
1,033,782
+180,729
| +21% | +$7.83M | 0.18% | 147 |
|
|
2022
Q3 | $33M | Buy |
853,053
+269,361
| +46% | +$10.8M | 0.14% | 177 |
|
|
2022
Q2 | $21.8M | Sell |
583,692
-60,738
| -9% | -$2.47M | 0.1% | 250 |
|
|
2022
Q1 | $28.5M | Buy |
644,430
+49,523
| +8% | +$2.15M | 0.11% | 203 |
|
|
2021
Q4 | $25.3M | Buy |
594,907
+13,272
| +2% | +$558K | 0.1% | 233 |
|
|
2021
Q3 | $25.2M | Sell |
581,635
-21,833
| -4% | -$966K | 0.1% | 207 |
|
|
2021
Q2 | $25.8M | Buy |
603,468
+24,588
| +4% | +$1.03M | 0.12% | 196 |
|
|
2021
Q1 | $22.4M | Buy |
578,880
+44,594
| +8% | +$1.69M | 0.12% | 207 |
|
|
2020
Q4 | $19.2M | Buy |
534,286
+48,028
| +10% | +$1.73M | 0.11% | 216 |
|
|
2020
Q3 | $18.6M | Buy |
486,258
+25,099
| +5% | +$967K | 0.12% | 208 |
|
|
2020
Q2 | $16.2M | Buy |
461,159
+76,047
| +20% | +$2.74M | 0.11% | 218 |
|
|
2020
Q1 | $12.6M | Buy |
385,112
+187,067
| +94% | +$7.31M | 0.1% | 225 |
|
|
2019
Q4 | $8.96M | Buy |
198,045
+17,365
| +10% | +$727K | 0.06% | 339 |
|
|
2019
Q3 | $7.35M | Buy |
180,680
+38,832
| +27% | +$1.65M | 0.06% | 354 |
|
|
2019
Q2 | $6.1M | Buy |
141,848
+11,530
| +9% | +$443K | 0.05% | 398 |
|
|
2019
Q1 | $5M | Sell |
130,318
-6,697
| -5% | -$256K | 0.04% | 444 |
|
|
2018
Q4 | $4.84M | Buy |
137,015
+2,613
| +2% | +$94.8K | 0.05% | 422 |
|
|
2018
Q3 | $5.17M | Sell |
134,402
-8,651
| -6% | -$302K | 0.05% | 449 |
|
|
2018
Q2 | $4.68M | Sell |
143,053
-2,355
| -2% | -$71K | 0.04% | 482 |
|
|
2018
Q1 | $3.97M | Buy |
145,408
+27,422
| +23% | +$745K | 0.04% | 517 |
|
|
2017
Q4 | $2.92M | Buy |
117,986
+71,031
| +151% | +$1.96M | 0.03% | 584 |
|
|
2017
Q3 | $1.37M | Sell |
46,955
-2,885
| -6% | -$79.7K | 0.01% | 804 |
|
|
2017
Q2 | $1.38M | Buy |
49,840
+5,513
| +12% | +$146K | 0.02% | 795 |
|
|
2017
Q1 | $1.1M | Sell |
44,327
-3,729
| -8% | -$90.7K | 0.01% | 839 |
|
|
2016
Q4 | $1.04M | Sell |
48,056
-11,297
| -19% | -$246K | 0.01% | 820 |
|
|
2016
Q3 | $1.41M | Buy |
59,353
+1,839
| +3% | +$43.9K | 0.02% | 726 |
|
|
2016
Q2 | $1.34M | Buy |
57,514
+11,136
| +24% | +$241K | 0.02% | 725 |
|
|
2016
Q1 | $872K | Buy |
46,378
+3,022
| +7% | +$53.1K | 0.01% | 821 |
|
|
2015
Q4 | $799K | Sell |
43,356
-6,347
| -13% | -$114K | 0.01% | 804 |
|
|
2015
Q3 | $816K | Buy |
49,703
+11,007
| +28% | +$188K | 0.01% | 818 |
|
|
2015
Q2 | $685K | Buy |
38,696
+7,774
| +25% | +$139K | 0.01% | 851 |
|
|
2015
Q1 | $549K | Sell |
30,922
-2,619
| -8% | -$41.4K | 0.01% | 897 |
|
|
2014
Q4 | $444K | Buy |
33,541
+835
| +3% | +$10.7K | 0.01% | 940 |
|
|
2014
Q3 | $386K | Buy |
32,706
+5,857
| +22% | +$73.8K | 0.01% | 940 |
|
|
2014
Q2 | $343K | Buy |
26,849
+34
| +0.1% | +$442 | ﹤0.01% | 1113 |
|
|
2014
Q1 | $363K | Sell |
26,815
-7,994
| -23% | -$105K | 0.01% | 1024 |
|
|
2013
Q4 | $418K | Buy |
34,809
+3,772
| +12% | +$44.6K | 0.01% | 934 |
|
|
2013
Q3 | $364K | Sell |
31,037
-1,185
| -4% | -$12.8K | 0.01% | 925 |
|
|
2013
Q2 | $299K | Buy |
+32,222
| New | +$273K | 0.01% | 932 |
|
Other funds holding BSX
Natixis Advisors's BSX Position: Q2 2026 in Review
Natixis Advisors reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $29.5M and leaving 1,325,522 shares worth $56.6M. The position accounts for 0.06% of the portfolio, ranked #277.
Natixis Advisors first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $269M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Natixis Advisors held 1,325,522 shares of Boston Scientific worth $56.6M as of Q2 2026.
- Natixis Advisors sold 542,522 Boston Scientific shares in Q2 2026, an estimated $29.5M.
- Boston Scientific made up 0.06% of Natixis Advisors's portfolio in Q2 2026, its #277 holding.
- Natixis Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Natixis Advisors's Boston Scientific position peaked at $269M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.